National Biodefense Science Board Public Meeting, 16019 [2023-05274]

Download as PDF Federal Register / Vol. 88, No. 50 / Wednesday, March 15, 2023 / Notices provide rapid and flexible support to Zanzibar to accelerate evidence-based, person-centered HIV prevention and treatment program implementation at both facility and community levels, align HSS strengthening activities towards epidemic control, and ensure a comprehensive, coordinated, and strategic approach to the HIV response by organizing policies and interventions supported by reliable epidemiologic and program data. Funding amounts for years 2–5 will be set at continuation. The period for this award will be September 30, 2023, through September 29, 2028. DATES: FOR FURTHER INFORMATION CONTACT: lotter on DSK11XQN23PROD with NOTICES1 Angela Schaad, Center for Global Health, Centers for Disease Control and Prevention, 2448 Albert Luthuli Rd, NIMR Complex | P.O. Box 9123 Dar es Salaam, Tanzania, Telephone: 255 677 680 051, Email: kin7@cdc.gov. Dated: March 9, 2023. Terrance Perry, Chief Grants Management Officer, Centers for Disease Control and Prevention. [FR Doc. 2023–05252 Filed 3–14–23; 8:45 am] BILLING CODE 4163–18–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Biodefense Science Board Public Meeting Administration for Strategic Preparedness and Response (ASPR), Department of Health and Human Services (HHS). ACTION: Notice. AGENCY: The National Biodefense Science Board (NBSB or the Board), authorized under the Public Health Service (PHS) Act, as added by the Pandemic and All-Hazards Preparedness Act of 2006 and amended SUPPLEMENTARY INFORMATION: The by the Pandemic and All-Hazards single-source award will enhance Preparedness Reauthorization Act, will collaboration between PEPFAR and the hold a virtual, public meeting on May MOHZ to scale up HIV/TB services and 4, 2023, at 2:00 p.m. ET. The NBSB, improve quality of service delivery by managed and operated by the ASPR, reducing barriers to access. provides expert advice and guidance to the Secretary of HHS regarding current The MOHZ is in a unique position to and future chemical, biological, conduct this work in terms of its radiological, and nuclear threats, and mandate and existing infrastructure to other disaster preparedness and address the HIV strategy throughout response matters. A detailed agenda and Zanzibar. Zoom registration instructions will be Summary of the Award available on the ASPR/NBSB public meeting web page at least 10 days in Recipient: Ministry of Health Zanzibar advance of the meeting. (MOHZ). FOR FURTHER INFORMATION CONTACT: Purpose of the Award: The purpose of CAPT Christopher Perdue, NBSB this award is to provide rapid and Designated Federal Official, via email flexible support to Zanzibar to message to NBSB@hhs.gov or (202) 480– accelerate evidence-based, person7226. centered HIV prevention and treatment SUPPLEMENTARY INFORMATION: program implementation at both facility Procedures for Public Participation: and community levels, align HSS The link to pre-register for the public strengthening activities towards meeting will be posted on the meeting epidemic control, and ensure a website. The online meeting will use a comprehensive, coordinated, and webinar format and include American strategic approach to the HIV response Sign Language interpretation and live by organizing policies and interventions captioning. supported by reliable epidemiologic and Members of the public may provide program data. written comments or submit questions to the NBSB at any time via email to Amount of Award: The approximate NBSB@hhs.gov and are encouraged to year 1 funding amount will be $5,000,000 in Federal Fiscal Year (FYY) provide comments related to the draft 2023 funds, subject to the availability of recommendations when those are posted. Additionally, the NBSB invites funds. Funding amounts for years 2–5 stakeholders to request up to seven will be set at continuation. minutes to address the Board in-person Authority: This program is authorized during the meeting. The Board wishes to under Public Law 108–25 (the United hear from experts from relevant States Leadership Against HIV AIDS, biomedical, biodefense, or health Tuberculosis and Malaria Act of 2003). industries; faculty or researchers at Period of Performance: September 30, academic institutions; health 2023 through September 29, 2028. professionals, health system experts, or VerDate Sep<11>2014 18:48 Mar 14, 2023 Jkt 259001 SUMMARY: PO 00000 Frm 00068 Fmt 4703 Sfmt 4703 16019 those who work in health care consumer organizations; or experts in state, Tribal, territorial, or local government agencies. Requests to provide remarks to the NBSB during the public meeting must be sent to NBSB@hhs.gov by April 21, 2023. In that request, please provide the speaker’s name, title, position, and organization, with a brief description of the topic they will address. Requests to speak to the Board will be approved in consultation with the Board Chairperson and based on time available during the meeting. Dawn O’Connell, Assistant Secretary for Preparedness and Response. [FR Doc. 2023–05274 Filed 3–14–23; 8:45 am] BILLING CODE 4150–37–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Substance Abuse and Mental Health Services Administration Agency Information Collection Activities: Submission for OMB Review; Comment Request Periodically, the Substance Abuse and Mental Health Services Administration (SAMHSA) will publish a summary of information collection requests under OMB review, in compliance with the Paperwork Reduction Act (44 U.S.C. Chapter 35). To request a copy of these documents, call the SAMHSA Reports Clearance Officer on (240) 276–0361. Project: Mandatory Guidelines for Federal Workplace Drug Testing Programs (OMB No. 0930–0158)— Extension SAMHSA will request OMB approval for extension of the Federal Drug Testing Custody and Control Form (CCF) for federal agency and federally regulated drug testing programs which must comply with the HHS Mandatory Guidelines for Federal Workplace Drug Testing Programs using Urine (UrMG) dated January 23, 2017 (82 FR 7920) and using Oral Fluid (OFMG) dated October 25, 2019, and OMB approval for information provided by test facilities (laboratories and Instrumented Initial Test Facilities, IITFs) for the National Laboratory Certification Program (NLCP). The CCF is used by all federal agencies and employers regulated by the Department of Transportation (DOT) and the Nuclear Regulatory Commission (NRC) to document the collection and chain of custody of urine specimens at the collection site, for HHS-certified test facilities to report results, and for E:\FR\FM\15MRN1.SGM 15MRN1

Agencies

[Federal Register Volume 88, Number 50 (Wednesday, March 15, 2023)]
[Notices]
[Page 16019]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2023-05274]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES


National Biodefense Science Board Public Meeting

AGENCY: Administration for Strategic Preparedness and Response (ASPR), 
Department of Health and Human Services (HHS).

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: The National Biodefense Science Board (NBSB or the Board), 
authorized under the Public Health Service (PHS) Act, as added by the 
Pandemic and All-Hazards Preparedness Act of 2006 and amended by the 
Pandemic and All-Hazards Preparedness Reauthorization Act, will hold a 
virtual, public meeting on May 4, 2023, at 2:00 p.m. ET. The NBSB, 
managed and operated by the ASPR, provides expert advice and guidance 
to the Secretary of HHS regarding current and future chemical, 
biological, radiological, and nuclear threats, and other disaster 
preparedness and response matters. A detailed agenda and Zoom 
registration instructions will be available on the ASPR/NBSB public 
meeting web page at least 10 days in advance of the meeting.

FOR FURTHER INFORMATION CONTACT: CAPT Christopher Perdue, NBSB 
Designated Federal Official, via email message to [email protected] or (202) 
480-7226.

SUPPLEMENTARY INFORMATION: 
    Procedures for Public Participation: The link to pre-register for 
the public meeting will be posted on the meeting website. The online 
meeting will use a webinar format and include American Sign Language 
interpretation and live captioning.
    Members of the public may provide written comments or submit 
questions to the NBSB at any time via email to [email protected] and are 
encouraged to provide comments related to the draft recommendations 
when those are posted. Additionally, the NBSB invites stakeholders to 
request up to seven minutes to address the Board in-person during the 
meeting. The Board wishes to hear from experts from relevant 
biomedical, biodefense, or health industries; faculty or researchers at 
academic institutions; health professionals, health system experts, or 
those who work in health care consumer organizations; or experts in 
state, Tribal, territorial, or local government agencies. Requests to 
provide remarks to the NBSB during the public meeting must be sent to 
[email protected] by April 21, 2023. In that request, please provide the 
speaker's name, title, position, and organization, with a brief 
description of the topic they will address. Requests to speak to the 
Board will be approved in consultation with the Board Chairperson and 
based on time available during the meeting.

Dawn O'Connell,
Assistant Secretary for Preparedness and Response.
[FR Doc. 2023-05274 Filed 3-14-23; 8:45 am]
BILLING CODE 4150-37-P
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.